WallStreetZenWallStreetZen

NASDAQ: GNLN
Greenlane Holdings Inc Stock

$0.31+0.00 (+0%)
Updated Jun 2, 2023
GNLN Price
$0.31
Fair Value Price
$1.17
Market Cap
$4.96M
52 Week Low
$0.27
52 Week High
$8.39
P/E
-0.03x
P/B
0.06x
P/S
0.05x
PEG
N/A
Dividend Yield
N/A
Revenue
$114.51M
Earnings
-$110.62M
Gross Margin
21.4%
Operating Margin
-94.19%
Profit Margin
-96.6%
Debt to Equity
0.52
Operating Cash Flow
-$13M
Beta
1.31
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

GNLN Overview

Greenlane Holdings, Inc. develops and distributes cannabis accessories, child-resistant packaging, vape solutions, and lifestyle products in the United States, Canada, and Europe. It operates through two segments, Consumer Goods and Industrial Goods. The company provides consumption accessories, vaporizers, pipes, rolling papers and packaging, grinders, and apparel lines, as well as bubblers, rigs, and other smoking and vaporization related accessories and merchandise. It offers its products under the VIBES rolling papers, Pollen Gear, the Marley Natural accessory line, Aerospaced & Groove grinders, Marley Natural, K. Haring Glass Collections, Eyce silicone pipes, Higher Standards, and DaVinci vaporizers brands. The company also operates e-commerce websites, such as Vapor.com, Higherstandards.com, Aerospaced.com, DaVincivaporizer.com, Harringglass.com, Eycemolds.com, Vapor.ca, Vaposhop.com, and Puffitup.com. It serves customers through a network of 8,500 smoke shops, cannabis dispensaries, and specialty retailers. Greenlane Holdings, Inc. was founded in 2005 and is headquartered in Boca Raton, Florida.

Zen Score

Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how GNLN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

GNLN ($0.31) is undervalued by 73.45% relative to our estimate of its Fair Value price of $1.17 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
GNLN ($0.31) is significantly undervalued by 73.45% relative to our estimate of its Fair Value price of $1.17 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
GNLN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more GNLN due diligence checks available for Premium users.

Be the first to know about important GNLN news, forecast changes, insider trades & much more!

GNLN News

Valuation

GNLN fair value

Fair Value of GNLN stock based on Discounted Cash Flow (DCF)
Price
$0.31
Fair Value
$1.17
Undervalued by
73.45%
GNLN ($0.31) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
GNLN ($0.31) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
GNLN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

GNLN price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.03x
Industry
11.07x
Market
52.69x

GNLN price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.06x
Industry
1.33x
GNLN is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

GNLN's financial health

Profit margin

Revenue
$24.0M
Net Income
-$10.2M
Profit Margin
-42.5%
GNLN's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
GNLN's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$130.0M
Liabilities
$44.5M
Debt to equity
0.52
GNLN's short-term assets ($62.79M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
GNLN's short-term assets ($62.79M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
GNLN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$1.9M
Investing
-$176.0k
Financing
-$8.2M
GNLN's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

GNLN vs Pharmaceutical Retailer Stocks

TickerMarket Cap1d %P/EP/B
GNLN$4.96M0.00%-0.03x0.06x
BIMI$4.74M+3.85%-0.19x0.62x
CJJD$4.10M+4.63%-0.83x0.18x
MEDS$3.32M-16.67%-0.90x5.07x
LFLY$11.90M+3.94%0.57x-1.08x

Greenlane Holdings Stock FAQ

What is Greenlane Holdings's quote symbol?

(NASDAQ: GNLN) Greenlane Holdings trades on the NASDAQ under the ticker symbol GNLN. Greenlane Holdings stock quotes can also be displayed as NASDAQ: GNLN.

If you're new to stock investing, here's how to buy Greenlane Holdings stock.

What is the 52 week high and low for Greenlane Holdings (NASDAQ: GNLN)?

(NASDAQ: GNLN) Greenlane Holdings's 52-week high was $8.39, and its 52-week low was $0.27. It is currently -96.3% from its 52-week high and 14.81% from its 52-week low.

How much is Greenlane Holdings stock worth today?

(NASDAQ: GNLN) Greenlane Holdings currently has 15,993,137 outstanding shares. With Greenlane Holdings stock trading at $0.31 per share, the total value of Greenlane Holdings stock (market capitalization) is $4.96M.

Greenlane Holdings stock was originally listed at a price of $422.00 in Apr 18, 2019. If you had invested in Greenlane Holdings stock at $422.00, your return over the last 4 years would have been -99.93%, for an annualized return of -83.54% (not including any dividends or dividend reinvestments).

How much is Greenlane Holdings's stock price per share?

(NASDAQ: GNLN) Greenlane Holdings stock price per share is $0.31 today (as of Jun 2, 2023).

What is Greenlane Holdings's Market Cap?

(NASDAQ: GNLN) Greenlane Holdings's market cap is $4.96M, as of Jun 6, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Greenlane Holdings's market cap is calculated by multiplying GNLN's current stock price of $0.31 by GNLN's total outstanding shares of 15,993,137.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.